COLUMBIA, S.C. (WIS) – The West Columbia-based Nephron Sterile Compounding Center LLC is recalling 2.1 million doses of medicine and medical equipment. The enforcement report filed by the FDA says the products listed in the recall have a , “Lack of Assurance of Sterility.”
In total the company is recalling 2,158,351 pieces of medicine and equipment, that include syringes and bags. The nationwide recall started on May 18, 2022.
Products listed in the report include:
- 8.4% Sodium Bicarbonate Injection
- Calcium Gluconate Injection
- Epinephrine Injection
- Fentanyl Citrate in 0.9% Sodium Chloride Injection
- Glycopyrrolate Injection
- Hydromorphone HCl Injection
- Ketamine Hydrochloride Injection
- Labetalol HCl Injection
- Lidocaine HCl Injection
- Neostigmine Methylsulfate Injection
- Oxytocin 30 Units/500 mL
- Phenylephrine HCl Injection
- Rocuronium Bromide Injection
- Succinylcholine Chloride Injection
WIS reached out to Nephron on the recall and Lou Kennedy, Nephron Pharmaceuticals Corporation CEO & Owner issued a statement,
“Out of an abundance of caution, Nephron is proactively cooperating with the Food and Drug Administration on a voluntary recall of a limited number of product lots. We do not take this lightly. While there has been no impact to patient safety, and there is no evidence of contamination, Nephron has decided in the interest of patients to proceed with this recall process. The company is prepared to provide the resources and information necessary to health care providers and patients to make certain they have anything they need and any questions answered. They remain our top priority.”
A full listing of the impacted products can be found in the report, linked here.
Copyright 2022 WIS. All rights reserved.
Notice a spelling or grammar error in this article? Click or tap here to report it. Please include the article’s headline.